Sign in to view content

High-Dose Anti-VEGF: Cross-Trial Analysis of Different Doses and Antagonists for the Treatment of Diabetic Macular Edema

Quan Dong Nguyen, MD, MSc, FARVO, FASRS

Video
Published 2019

Related

Diabetic Retinopathy 2 Symposium
Annual Meeting Talks
2020
Prophylactic Ranibizumab for Exudative AMD in Vulnerable Eyes With Nonexudative AMD Trial (PREVENT) A Prospective Controlled Clinical Trial
Maziar Lalezary, MD
Annual Meeting Talks
2018
Incidence of New Diabetic Macular Edema in Fellow Eyes of Patients in the VISTA and VIVID Studies
Sumit Sharma, MD, FASRS
Annual Meeting Talks
2020

Category: Diabetic Retinopathy

See more